Status:
COMPLETED
Single Bolus Dose of Ketodex Versus Ketofol For Prevention Of Emergence Agitation In Adults Undergoing Nasal Surgeries
Lead Sponsor:
Zagazig University
Conditions:
Agitation, Emergence
Eligibility:
All Genders
21-60 years
Phase:
EARLY_PHASE1
Brief Summary
* emergence agitation is seen in around 68% after nasal surgeries. Agitated patients needs more staff and nurses to control their abnormal movement which leads to self extubation , removal of catheter...
Detailed Description
The incidence of emergence agitation (EA) after nasal surgeries is relatively high , it is reported to be 68% (1).The precise mechanism is not known. Awake extubation after nasal surgeries is preferre...
Eligibility Criteria
Inclusion
- Patient acceptance.
- Both gender.
- Age (21-60) years old.
- patient with Body Mass Index (BMI) (25-35kg/m²).
- American Society of Anesthesiologist (ASA) I / II
- Adult patient scheduled to elective nasal surgeries
Exclusion
- \- Patient with difficult airway (mallampati III,IV).
- Altered mental status (psychiatric and anxiety disorder).
- Post traumatic stress disorders.
- History of allergy to study drugs.
- Patient on sedative or hypnotic medication.
- Patients with chronic pain or on painkiller.
- Patients with severe hepatic or kidney impairment.
- Patients having a history of thyrotoxicosis, hypertension, cardiac , chest or neurological disease.
- Patient receiving B agonist.
- Pregnant or breast feeding female.
Key Trial Info
Start Date :
July 3 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 23 2019
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04018157
Start Date
July 3 2019
End Date
November 23 2019
Last Update
November 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine
Zagazig, Elsharkia, Egypt, 022/055